跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
I-105
首页
药物
I-105
I-105
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for treating neuropsychiatric disorders
US 6974821 B2
申请人: GEN HOSPITAL CORP
优先权: 2001
US
7 件公开
Method for enhancing the cleavage activity of I-CreI derived meganucleases
EP 2770052 A1
申请人: CELLECTIS
优先权: 2007
CN
EP
US
WO
6 件公开
Antibodies and related molecules and uses thereof
US 11566075 B2
申请人: CANCER RESEARCH TECH LTD
优先权: 2016
CN
US
WO
4 件公开
Antibodies, uses thereof and conjugates thereof
US 11485792 B2
申请人: POLYTHERICS LTD
优先权: 2016
CN
EP
US
4 件公开
MODIFIED LIPIDATED RELAXIN B CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
EP 3746467 B1
申请人: SANOFI SA
优先权: 2018
CN
EP
US
4 件公开
Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
CN 103224495 B
申请人: GUERBET SA
优先权: 2005
CN
EP
4 件公开
Mesalazine tablet having improved dissolution
EP 2425826 A1
申请人: DISPHAR INT BV
优先权: 2010
CN
EP
US
3 件公开
HYDROCHLORINATION OF ALKENES UNDER MILD CONDITIONS
EP 4450482 A1
申请人: CENTRE NAT RECH SCIENT
优先权: 2023
EP
WO
3 件公开
Soap bar compositions comprising alpha sulfonated fatty acid alkyl estersand polyhydridic alcohols and process for producing same
US 2005124515 A1
申请人: OSPINAL CARLOS E
优先权: 2003
CN
US
2 件公开
A COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B CELL DEPLETION
WO 2013093919 A2
申请人: YEDA RES & DEV
优先权: 2011
CN
WO
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈